Crescent Diagnostics

Advanced warning for osteoporosis

Reducing costs for healthcare providers

Osteoporosis is a serious condition that is frequently under diagnosed and consequently under treated.

Crescent Diagnostics have worked with BFG Healthcare to develop a consumer osteoporosis testing kit that will allow consumers to have access to Crescent’s Bone Quality Test (BQT).

A typical manifestation of osteoporosis is a hip fracture and require hospitalisation. It mainly affects postmenopausal women but can also affect men, and osteoporosis related hip fractures are a huge cost for healthcare providers. There is currently no quick way to check for osteoporosis but Crescent’s pioneering Osentia screening test is about to change that.

The consumer buys the osteoporosis testing kit at the local pharmacy and mails a nail clipping to the lab using the included vial and prepaid envelope. The lab inserts the clipping into a Raman spectrometer, where the sample is excited and produces a spectrum. Proprietary algorithms tag the sample according to the osteoporosis risk. A lab report is then sent back to the patient using a simple green-amber-red type of system – green means you’re fine; amber means you are at risk of osteoporosis and might consider making some lifestyle changes; red indicates that you could have a problem and should see your general practitioner.

Project Details


Crescent Diagnostics

Projects commissioned

Marketing strategy
Name Generation
Packaging design
Regulatory compliance
Website design
Exhibition design


Share this story

Share on linkedin
Share on twitter
Share on facebook
Share on google
Share on pinterest
Share on email
BFG Healthcare logo

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.